Related Experiment Video
Updated: Jun 6, 2025
05:28
Analysis of Fecal Microbiota Dynamics in Lupus-Prone Mice Using a Simple, Cost-Effective DNA Isolation Method
Published on: May 2, 2022
2.1K
Gut Microbiota's role in lipoma development: evidence from mendelian randomization
Yuxin Li1, Jiahao Chen2, Hang Yao3
1Graduate School of Jiangxi University of Traditional Chinese Medicine, Nanchang, China.
Frontiers in Genetics
|December 2, 2024
Summary
This study reveals a causal link between gut microbiome composition and lipoma development. Specific gut bacteria may protect against or promote lipoma formation, suggesting new therapeutic targets.
Area of Science:
- Microbiome Research
- Genetics
- Oncology
Background:
- Lipomas, benign tumors, impact patient well-being.
- Growing evidence links gut microbiome (GM) to lipoma incidence.
- Understanding this link is crucial for patient health.
Purpose of the Study:
- To investigate the potential causal relationship between the gut microbiome and lipoma development.
- To identify specific gut bacterial species associated with lipoma risk.
- To explore novel therapeutic strategies for lipoma prevention and treatment.
Main Methods:
- Two-sample Mendelian Randomization (MR) analysis.
- Utilized genome-wide association study (GWAS) data from MiBioGen and FinnGen.
- Employed five MR methods and performed sensitivity analyses to ensure robustness.
Main Results:
- Identified 18 gut bacterial genera associated with lipoma risk.
- Several bacterial groups, including Eubacterium rectale and Desulfovibrio, showed protective effects against different lipoma subtypes.
- Other bacteria, such as Lachnospiraceae UCG008, were associated with increased lipoma risk.
Conclusions:
- This MR study provides novel evidence for a causal association between the gut microbiome and lipoma development.
- Specific gut bacteria may play protective or detrimental roles in lipoma pathogenesis.
- Findings open avenues for future research into microbiome-based interventions for lipomas.
